Vyant Bio, Inc.
VYNT
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -13.83M | -18.01M | -22.69M | -43.28M | -44.28M |
| Total Depreciation and Amortization | 676.00K | 796.00K | 843.00K | 1.08M | 1.18M |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 1.33M | 2.84M | 7.28M | 27.77M | 28.06M |
| Change in Net Operating Assets | -1.14M | -942.00K | 891.00K | 1.04M | 578.00K |
| Cash from Operations | -12.96M | -15.32M | -13.68M | -13.39M | -14.46M |
| Capital Expenditure | -256.00K | -587.00K | -617.00K | -622.00K | -389.00K |
| Sale of Property, Plant, and Equipment | 190.00K | 190.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.82M | 3.85M | 3.95M | -63.00K | 4.00K |
| Cash from Investing | 3.75M | 3.45M | 3.34M | -685.00K | -385.00K |
| Total Debt Issued | 266.00K | 266.00K | 266.00K | 758.00K | 492.00K |
| Total Debt Repaid | -461.00K | -246.00K | -191.00K | -168.00K | -109.00K |
| Issuance of Common Stock | 458.00K | 458.00K | -- | 37.00K | 37.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 42.00K | -122.00K | -224.00K | -287.00K | -288.00K |
| Cash from Financing | 305.00K | 356.00K | -149.00K | 340.00K | 132.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -72.00K | -72.00K | -72.00K | -72.00K |
| Net Change in Cash | -8.91M | -11.58M | -10.57M | -13.81M | -14.78M |